CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
about
The role of CD4 T cells in the pathogenesis of murine AIDS.Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells.Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.Methamphetamine inhibits Toll-like receptor 9-mediated anti-HIV activity in macrophagesMonitoring Therapeutic Treatments against Burkholderia Infections Using Imaging TechniquesTLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.Toll-Like Receptors and Tissue Remodeling: The Pro/Cons Recent Findings.The effects of CpG-ODNs and Chitosan adjuvants on the elicitation of immune responses induced by the HIV-1-Tat-based candidate vaccines in mice.
P2860
Q34651531-2D6192B8-1F14-4547-86B2-1DE895D71DCEQ36095520-04D33722-3C1C-422C-A9B0-ECCD8353E6A1Q36807121-28EB8A45-0F47-44C7-9B80-0D49C09E97AAQ36909391-EB20CE2C-DAF3-4D01-B09E-D05DE12A0428Q37025742-8BF22143-212D-4811-BCB7-0414B083032FQ37384332-BD3F78EC-689C-49B6-994C-3F4651B552C0Q37447389-30BA8F29-C582-476F-AF67-9CDEB9218A82Q38561820-D47C32AC-774E-45D0-84F9-76D509D89804Q38973146-37BDFAC1-0F77-4181-AE55-3AA143DCE107
P2860
CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@ast
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@en
type
label
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@ast
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@en
prefLabel
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@ast
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@en
P2860
P1433
P1476
CpG ODNs treatments of HIV-1 i ...... , hypothesis and implications.
@en
P2093
Yechiel Becker
P2860
P2888
P304
P356
10.1007/S11262-004-5632-2
P577
2005-03-01T00:00:00Z
P6179
1028754406